welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
- Bon Voyage: Traveling with a J-Pouch Part 2https://www.youtube.com/watch?v=x-9gR_LK...
- Different Surgical Strategies in the Treatment of Familial Adenomatous Polyposis: What’s the Role of the Ileor...Prophylactic (procto-) colectomy is the ...
- Is Laparoscopic Surgery an Option to Support Prophylactic Colectomy in Adolescent Patients with Familial Adenomatous...BACKGROUND : Prophylactic surgery is sti...
- Ileoanal Pouch Dysfunction and the Use of a Medena Catheter Following Hospital DischargeWith the advent of new surgical techniqu...
- Curcumin in Treating Patients With Familial Adenomatous PolyposisThis clinical trial studies curcumin in ...
- Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Survei...The primary objective of this chart revi...